About Hunter syndrome

Hunter syndrome, also known as mucopolysaccharidosis (MPS) type II, is a severe lysosomal storage condition that occurs when cells can’t break down long chains of sugar molecules. This causes progressive damage to many organs. Hunter syndrome primarily affects males, with symptoms starting in early childhood. Patients with severe disease experience progressive cognitive decline, breathing issues, and cardiac disease, and many pass away at a young age. New and more effective treatments are needed for Hunter syndrome.

The latest on our research

AllStripes is working on a natural history for Hunter syndrome with the biopharmaceutical company Denali Therapeutics. This research will help design better potential future trials and we are actively recruiting for participants in the U.S.